CJC / IPA / GHRP-2 Blend

CJC / IPA / GHRP-2 Blend is a three-peptide blend containing CJC-1295, ipamorelin, and GHRP-2 intended for controlled laboratory work. It is studied in experimental systems involving combined GHRH- and growth-hormone-secretagogue pathway models. Descriptions of research pathways do not establish safety, effectiveness, or suitability for human or veterinary use.

Research areas include:
• CJC-1295-related GHRH signaling
• Ipamorelin and GHRP-2 receptor-response comparison
• GH/IGF-1 and endocrine-feedback models
• Three-component identity, ratio, and stability testing

Research limitations and safety:
• Blend names and ratios are not standardized. Every formulation requires explicit ingredient amounts plus independent identity, purity, compatibility, and stability verification. Published or regulatory sources identify material safety uncertainties or adverse signals requiring particular caution.
• No dosing, administration, or therapeutic-use guidance is provided.

being sold for research only.